CNBC
Pizza chains are under pressure. GLP-1 use is only one part of the problem
* Pizza chains struggle with weaker consumer spending, more dining options, GLP-1 drugs
* US pizza restaurants down 9,600 since 2019 peak; 2025 sales fell 0.3%
* Domino's leads with +3% same-store sales; others down 2.5%-5%
Big pizza chains are struggling as weaker consumer spending, a wider variety of dining options, and GLP-1 medications weigh on sales. Since the pandemic, over 9,600 pizzerias have closed, and 2025 sales dropped 0.3%. Domino's posted 3% same-store growth, while Papa Johns and Pizza Hut saw declines of 2.5% and 5%. Shares of Papa Johns have lost two-thirds of their value since 2020. Competition from third-party delivery platforms, higher pizza prices, and frozen pizza alternatives have hurt the category. Chains are slow to adapt to nutrition trends, and GLP-1 drugs have reduced pizza spending by 22%. Despite these challenges, total pizza servings are down only 1%, and chains are launching new products to attract diners.
November 22, 2026 at 8:00 AMDPZPZZA